Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 7
1955 2
1956 48
1957 59
1958 27
1959 53
1960 71
1961 63
1962 64
1964 7
1965 93
1966 197
1967 198
1968 225
1969 222
1970 226
1971 218
1972 217
1973 206
1974 251
1975 229
1976 219
1977 239
1978 248
1979 239
1980 279
1981 289
1982 351
1983 363
1984 410
1985 448
1986 475
1987 452
1988 438
1989 529
1990 530
1991 509
1992 530
1993 459
1994 550
1995 617
1996 596
1997 609
1998 658
1999 666
2000 697
2001 814
2002 824
2003 866
2004 880
2005 1006
2006 1101
2007 1141
2008 1240
2009 1309
2010 1471
2011 1518
2012 1840
2013 2007
2014 2255
2015 2216
2016 2151
2017 1976
2018 2042
2019 1175
2020 42
Text availability
Article attribute
Article type
Publication date

Search Results

38,917 results
Results by year
Filters applied: . Clear all
Page 1
Progress in the treatment of advanced gastric cancer
Song Z, et al. Tumour Biol 2017 - Review. PMID 28671042
As surgical techniques improve and progress is made in traditional radiotherapy, chemotherapy, and the implementation of neoadjuvant therapy, the 5-year survival rate of early gastric cancer can reach >95%. ...Therefore, the main treatment for advanced gastric cancer is the combination of neoadjuvant chemoradiotherapy, molecular-targeted therapy, and immunotherapy. ...
As surgical techniques improve and progress is made in traditional radiotherapy, chemotherapy, and the implementation of neoadjuvant ther
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection
Smalley SR, et al. J Clin Oncol 2012 - Clinical Trial. PMID 22585691 Free PMC article.
Adjuvant radiochemotherapy remains a rational standard therapy for curatively resected gastric cancer with primaries T3 or greater and/or positive nodes....
Adjuvant radiochemotherapy remains a rational standard therapy for curatively resected gastric cancer with primaries T3 or greater an …
[Progress in conversion therapy for originally unresectable gastric cancer].
Chen X, et al. Zhonghua Wei Chang Wai Ke Za Zhi 2018 - Review. PMID 30370519 Chinese.
However, not all originally unresectable gastric cancer can benefit from conversion therapy due to the high heterogeneity of its biological behavior. ...Thus, this article focuses on reviewing research progress of conversion therapy for originally unresectable late stage gastric cancer....
However, not all originally unresectable gastric cancer can benefit from conversion therapy due to the high heterogeneity of its biol …
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis
GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group , et al. JAMA 2010 - Review. PMID 20442389
CONTEXT: Despite potentially curative resection of stomach cancer, 50% to 90% of patients die of disease relapse. Numerous randomized clinical trials (RCTs) have compared surgery alone with adjuvant chemotherapy, but definitive evidence is lacking. ...
CONTEXT: Despite potentially curative resection of stomach cancer, 50% to 90% of patients die of disease relapse. Numerous randomized …
[Conversion therapy of advanced gastric cancer].
Cheng X and Mao Z. Zhonghua Wei Chang Wai Ke Za Zhi 2017 - Review. PMID 29130225 Chinese.
Recently, a number of phase II( studies show an enormously ideal potential of conversion therapy in these patients. Conversion therapy uses rational chemotherapy, radiotherapy and targeted therapy and so on combined with MDT assessment to translate initial unresectable case to resectable one, which obviously prolongs survival time and improves quality of life. In this review, we address the indications, development and our experiences of conversion therapy in advanced GC, which looks forward to providing the reference to clinical diagnosis and treatment....
Recently, a number of phase II( studies show an enormously ideal potential of conversion therapy in these patients. Conversion the
Progress of preoperative and postoperative radiotherapy in gastric cancer
Zhang N, et al. World J Surg Oncol 2018 - Review. PMID 30213266 Free PMC article.
Meanwhile, radiotherapy is attracting increased attention as a crucial locoregional therapy. However, the application of radiotherapy in gastric carcinoma is still limited and radiation standards remain debatable. ...
Meanwhile, radiotherapy is attracting increased attention as a crucial locoregional therapy. However, the application of radiotherapy …
38,917 results
Jump to page
Feedback